OBJECTIVE: Phosphoinositide 3-kinase (PI3K) is required for murine adipocyte differentiation. However, a recent report concluded that PI3K was not involved in the differentiation of human preadipocytes into adipocytes. We have re-examined the role of PI3K in human preadipocyte differentiation, enrolling more patients and using more adipogenic indices. METHODS: Human preadipocytes, isolated from nine patients, were induced to differentiate in the presence or absence of 100 nM wortmannin. After 12-15 days, triacylglycerol accumulation and the expression of adipogenic markers (fatty acid synthase and adiponectin) were measured. RESULTS: A significant inhibition in triacylglycerol accumulation and in the induction of fatty acid synthase protein expression was observed, but there was no effect on adiponectin protein expression. CONCLUSION: Inhibition of PI3K reduces the differentiation of human preadipocytes into adipocytes, suggesting a role for this enzyme in the human adipogenic process.
Introduction
Disturbances in adipose tissue development and remodeling have adverse metabolic consequences. Obesity is an important component of the metabolic syndrome, a condition associated with increased risk of type 2 diabetes and cardiovascular disease. 1 Lipoatrophy also predisposes to similar metabolic and vascular disruption. 2 Either overabundant or inadequate adipose depots appear to perturb free fatty acid handling and/or adipokine production. Signaling through phosphoinositide 3-kinase (PI3K) has been proposed to be a key event required for the differentiation of preadipocytes into adipocytes. Pharmacological (wortmannin, LY294002) as well as genetic-based inhibition (dominant-negative PI3K construct) strategies have demonstrated that loss of PI3K activity impedes adipogenesis. 3, 4 A recent report using human preadipocytes in primary culture has reported that wortmannin did not inhibit their differentiation, leading the authors to conclude that PI3K was not involved in the adipogenic process in human cells. 5 Given the potential significance of such a divergence between the previous studies with murine preadipocytes and these results, we have re-examined the effect of wortmannin on the differentiation of human preadipocytes into adipocytes.
Methods
Isolation and cell culture of human preadipocytes Abdominal subcutaneous adipose tissue was obtained from nine patients (six men and three women) undergoing elective abdominal surgery (approved by the Research Ethics Committee of the Ottawa Health Research Institute). Mean age was 5474 y and mean body mass index was 2871 kg/m 2 (7s.e.). Preadipocytes were isolated as previously described, with minor modifications. 6, 7 Briefly, tissue was dissected to remove connective tissue and capillaries, and digested with collagenase CLS type 1 (200 U/g of tissue; Worthington). The digested tissue was subjected to progressive size filtration and centrifugation, followed by incubation in erythrocyte lysis buffer (0.15 M NH 4 Cl, 5.7 mM K 2 HPO 4 , 0.1 mM EDTA, pH 7.3). Preadipocytes were seeded at a density of 3 Â 10 4 cells/ cm 2 in DMEM supplemented with 20% fetal bovine serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 50 U/ml nystatin. Within 2 days of seeding, cells were induced to differentiate in serum-free medium consisting of DMEM:F12
(1:1), supplemented with 100 U/ml penicillin, 0.1 mg/ml streptomycin, 33 mM biotin, 17 mM pantothenate, 10 mg/ml transferrin, 0.2 nM triiodothyronine, 1 mM cortisol, 1 mM insulin, and for the first 4 days only, 25 nM dexamethasone, 0.5 mM isobutylmethylxanthine (IBMX), and 5 mM troglitazone (gift from Roche). When indicated, 100 nM wortmannin was added to the medium, which was replaced daily after the first 4 days. After approximately 2 weeks, cellular triacylglycerol (TG) was extracted and quantified spectrophotometrically, as previously described. 8, 9 Alternatively, cells were lysed and processed for immunoblotting.
Immunoblot analysis
Cells were lysed in Laemmli buffer 10 containing 1 mM sodium orthovanadate. Protein concentrations of the cellular lysates were determined by modified Lowry reaction (Sigma), using bovine serum albumin as standard. Equal amounts of solubilized proteins (5-15 mg) were separated by SDS-PAGE, electrophoretically transferred to a nitrocellulose membrane, and blotted with antibodies against fatty acid synthase (1 mg/ml; Transduction Laboratories), actin (0.4 mg/ ml; Santa Cruz), or adiponectin (1:1000; gift from P Scherer, Albert Einstein College of Medicine, New York). Immunoreactivity was detected by enhanced chemiluminescence (Amersham Pharmacia Biotech). The relative intensity of the immunoreactive bands was determined using Molecular Analyst imaging software (Bio-Rad), and expressed as integrated optical density (IOD) units.
Statistical analysis
ANOVA with Tukey's post-test for paired values (GraphPad Instat, version 3.05) was used to assess differences between means. A P-value o0.05 was considered significant.
Results
Human preadipocytes were induced to differentiate as described. Cellular TG increased from 231746 to 36567137 mg/mg protein (mean7s.e., n ¼ 5), a 16-fold increase. A robust increase in fatty acid synthase and adiponectin levels was clearly observed with immunoblot analysis. Addition of wortmannin to the differentiation medium reduced the accumulation of TG by 1677% (mean7s.e.; n ¼ 5; Po0.001), and the levels of fatty acid synthase by 23710% (mean7s.e.; n ¼ 9; Po0.05) (Figure 1 
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In contrast, another adipocyte-specific marker, adiponectin, was not reduced; a nonsignificant trend toward increased expression was observed. Expression of actin was similar in all lanes, and served as loading control. 11 Since wortmannin may lose activity over prolonged periods in cell culture medium, we replaced the medium daily, except during the first 4 days, a period when the cells are undergoing extensive shape change and do not withstand medium manipulation. A representative series of photomicrographs of preadipocytes, from a single patient, that were differentiated in the presence or absence of wortmannin is also shown.
Discussion
Our data confirm that human preadipocytes, as is the case for murine preadipocytes, depend on PI3K to undergo adipogenesis, as assessed by lipid accumulation and expression of the late marker fatty acid synthase. Wortmannin was recently reported to have no effect on human adipogenesis, as assessed by measurement of lipid content. 5 These authors concluded that a requirement for PI3K was a feature restricted to murine preadipocyte cell lines that undergo an early mitotic clonal expansion phase. However, their study was limited in that only four independent samples were studied, and it was not clearly stated if these were from four different patients. Furthermore, they replaced wortmannin every 2-3 days, and this was likely insufficient, since wortmannin is known to lose activity in aqueous solutions. 12 In addition, the quantitative data reported by these authors on the effect of wortmannin on lipid accumulation (Oil Red O spectrophotometry) were normalized to 100%, and the undifferentiated control values were not provided, making it difficult to assess how strong the absolute differentiation response was. We have shown that with daily replacement of the medium, thus minimizing loss of wortmannin activity, there is an inhibition of adipogenesis by this PI3K inhibitor in human preadipocytes. We included a larger number of patients, which may have allowed us to detect the inhibition, since preadipocyte samples can display significant donor heterogeneity.
The differentiation of human preadipocytes using serumfree conditions proceeds in the absence of a clonal expansion phase. The inhibition of lipid accumulation and induction of fatty acid synthase expression observed in our studies imply that wortmannin can inhibit other adipogenic events independent of the clonal expansion phase.
Human adipogenesis was incompletely inhibited by wortmannin; the extent of the inhibition was comparable to that observed by others in response to rapamcyin and SB203580, inhibitors of the mammalian target of rapamycin (mTOR) and p38 MAPK, respectively. 5 It remains possible that under these differentiation conditions, inhibition of PI3K is not complete or sustained, or that supplementary PI3K-independent signaling pathways are operative. Some components of the differentiation program would appear to display different degrees of dependence on PI3K, accounting for the lack of inhibition of adiponectin. Future investigations assessing the effect of other inhibitors of PI3K, as well as examining a greater number of adipogenic markers, should be informative. Very recently, a mutation in the PI3K target, Akt/PKB, was found to cause lipodystrophy. 13 Our data demonstrating a partial effect of PI3K on human adipogenesis are consistent with that report. Further detailed analysis of which parts of the human adipogenic program are more or less sensitive to PI3K will be of interest, and will provide a more thorough understanding of adipose tissue remodeling in health and obesity. This is important, as impairment in adipogenesis in the obese has been suggested to be a key event predisposing to adipocyte hypertrophy, greater insulin resistance, and ectopic fat accumulation and dysfunction in skeletal muscle, liver, and pancreatic beta cells.
